Merix/Glaxo Cold Sore Cold War Ends With Settlement
This article was originally published in The Tan Sheet
Executive Summary
The cold sore treatment cold war between competing manufacturers Merix Pharmaceutical Corp. and GlaxoSmithKline ended this month when the firms settled their multi-court false advertising dispute after more than four years of litigation